Realcan Pharmaceutical Group Co Ltd - Class A

SZSE:002589 (China)   Class A
Â¥ 3.00 (-1.96%) Dec 25
111.11
P/B:
0.82
Market Cap:
Â¥ 4.51B ($ 630.85M)
Enterprise V:
Â¥ 6.94B ($ 950.88M)
Volume:
32.52M
Avg Vol (2M):
58.31M
Trade In:
Volume:
32.52M
Avg Vol (2M):
58.31M

Business Description

Description
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.
Name Current Vs Industry Vs History
Cash-To-Debt 0.67
Equity-to-Asset 0.34
Debt-to-Equity 1.28
Debt-to-EBITDA 69.49
Interest Coverage 0.28
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.89
Distress
Grey
Safe
Beneish M-Score -2.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 19.17
9-Day RSI 32.07
14-Day RSI 40.13
6-1 Month Momentum % 45.37
12-1 Month Momentum % -3.38

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.14
Quick Ratio 1.05
Cash Ratio 0.46
Days Inventory 47.79
Days Sales Outstanding 178.36
Days Payable 222.97

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 0.65
Dividend Payout Ratio 0.48
Forward Dividend Yield % 0.65
5-Year Yield-on-Cost % 0.68
Shareholder Yield % -38.1
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Realcan Pharmaceutical Group Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 7,985.499
EPS (TTM) (Â¥) 0.027
Beta 0.6
Volatility % 41.53
14-Day RSI 40.13
14-Day ATR (Â¥) 0.130842
20-Day SMA (Â¥) 3.2825
12-1 Month Momentum % -3.38
52-Week Range (Â¥) 2.05 - 3.67
Shares Outstanding (Mil) 1,504.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Realcan Pharmaceutical Group Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Realcan Pharmaceutical Group Co Ltd Stock Events

Financials Calendars
Event Date Price(Â¥)
No Event Data

Realcan Pharmaceutical Group Co Ltd Frequently Asked Questions

What is Realcan Pharmaceutical Group Co Ltd(SZSE:002589)'s stock price today?
The current price of SZSE:002589 is ¥3.00. The 52 week high of SZSE:002589 is ¥3.67 and 52 week low is ¥2.05.
When is next earnings date of Realcan Pharmaceutical Group Co Ltd(SZSE:002589)?
The next earnings date of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) is .
Does Realcan Pharmaceutical Group Co Ltd(SZSE:002589) pay dividends? If so, how much?
The  Dividend Yield %  of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) is 0.65% (As of Today), Highest Dividend Payout Ratio of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) was 0.48. The lowest was 0.05. And the median was 0.08. The  Forward Dividend Yield % of Realcan Pharmaceutical Group Co Ltd(SZSE:002589) is 0.65%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release